PETERS, 1953 - Google Patents
Significance of biochemical lesions in the pyruvate oxidase systemPETERS, 1953
View PDF- Document ID
- 6043107716959912262
- Author
- PETERS R
- Publication year
- Publication venue
- British Medical Bulletin
External Links
Snippet
The term" biochemical lesion"(Peters, 1936) was introduced twenty-three years ago, at a time when no proof existed of its reality, to crystallize the idea that pathological disturbances in tissues might be initiated by changes in their biochemistry. If proved, it implies that to …
- 230000003902 lesions 0 title abstract description 16
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PETERS | Significance of biochemical lesions in the pyruvate oxidase system | |
| Peters | Croonian lecture-lethal synthesis | |
| Peters | Biochemical Lesions and Lethal Synthesis: International Series of Monographs on Pure and Applied Biology: Modern Trends in Physiological Sciences | |
| US4323581A (en) | Method of treating carcinogenesis | |
| DK1856085T3 (en) | FLAVONOID COMPOUNDS AND APPLICATIONS THEREOF | |
| RU2223095C2 (en) | New analogs of fatty acids for treating primary and secondary restenosis | |
| US4898870A (en) | Pyrroloquinoline quinone compounds useful as an enzyme inhibitor | |
| EP3284463B1 (en) | Nitroxyl donors with improved therapeutic index | |
| Aldridge et al. | Neurotoxic and biochemical properties of some triaryl phosphates | |
| EA011074B1 (en) | Hydrazide-containing cftr inhibitor compounds and uses thereof | |
| Welton et al. | Biological activities of a chemically synthesized form of leukotriene E4 | |
| Rich et al. | Severe complications of intravenous phytonadione therapy: two cases, with one fatality | |
| Prandoni et al. | The Anti-Coagulants: Heparin and the Dicoumarin-3, 3'Methylene-Bis-(4-Hydroxycoumarin) | |
| US5512573A (en) | Use of phthaloylhydrazide derivatives as anti-hypoxic and defensive agents | |
| KR20080061431A (en) | New bisphenyl derivatives, a method for preparing thereof, and use as adp-ribosyl cyclase inhibitors | |
| US3819830A (en) | Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor | |
| Samhoun et al. | Actions and interactions of lipoxygenase and cyclo-oxygenase products in respiratory and vascular tissues | |
| Burgen et al. | Quantitative studies of procaine metabolism in the cat | |
| JPS60184011A (en) | Immuno-regulator | |
| ES2886345T3 (en) | Methods and compositions for the treatment of arteriosclerotic vascular diseases | |
| JPH0597674A (en) | Collagenase inhibitor | |
| US4124724A (en) | Crystalline caffeic acid derivatives and compositions and method for treating snakebite | |
| Sorenson et al. | A Synthetic Anticoagulant: A Polysulfuric Acid Ester of Polyanhydromannuronic Acid (Paritol) Experience with Its Use in Man | |
| ES2222717T3 (en) | USE OF SUCCINIC ACID OR ITS SALTS AND METHOD OF TREATMENT OF INSULIN RESISTANCE. | |
| Štětinová et al. | Effects of known and potential antioxidants on animal models of pathological processes (diabetes, gastric lesions, allergic bronchospasm) |